Nicotinamide riboside shows promise for treatment of Parkinson’s disease

Reprinted with the kind permission of Life Extension. June 13 2018. The June 5, 2018 issue of Cell Reports documented findings from German researchers of a potential benefit for nicotinamide riboside in Parkinson’s disease. Nicotinamide riboside is a precursor of nicotinamide adenine dinucleotide (NAD+), an enzyme that plays an important role in the maintenance of healthy cellular metabolism, including … Continue reading Nicotinamide riboside shows promise for treatment of Parkinson’s disease